What is it about?
For patients with advanced non-small cell lung cancer without treatable mutations, the combination of number and organ location of their metastases is useful to define high- and low-risk lung cancers. Liver metastases and more than four metastases outside the chest are associated with worse prognosis.
Featured Image
Read the Original
This page is a summary of: Stage IV lung cancer: the relevance of tumour profile for the construction of prognostic groups, European Respiratory Journal, February 2023, European Respiratory Society (ERS),
DOI: 10.1183/13993003.02094-2022.
You can read the full text:
Contributors
The following have contributed to this page







